These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 458054)

  • 1. Complement and contrast material reactors.
    Lasser EC; Lang JH; Lyon SG; Hamblin AE
    J Allergy Clin Immunol; 1979 Aug; 64(2):105-12. PubMed ID: 458054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in complement and coagulation factors in a patient suffering a severe anaphylactoid reaction to injected contrast material: some considerations of pathogenesis.
    Lasser EC; Lang JH; Lyon SG; Hamblin AE
    Invest Radiol; 1980; 15(6 Suppl):S6-12. PubMed ID: 7203950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aspirin on complement in vivo.
    Voigtländer V; Hänsch GM; Rother U
    Int Arch Allergy Appl Immunol; 1980; 61(2):145-9. PubMed ID: 7351346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of prekallikrein, alpha-2-macroglobulin and C1-esterase inhibitor in patients with urticarial reaction to contrast media.
    Mikkonen R; Aronen HJ; Kivisaari L; Piilonen A; Syrjälä M
    Acta Radiol; 1997 May; 38(3):466-73. PubMed ID: 9191442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation following intravenous contrast material administration.
    Lieberman P; Siegle RL
    J Allergy Clin Immunol; 1979 Jul; 64(1):13-7. PubMed ID: 447947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1).
    Windfuhr JP; Alsenz J; Loos M
    Mol Immunol; 2005 Apr; 42(6):657-63. PubMed ID: 15781109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation systems in contrast idiosyncrasy.
    Lasser EC; Hang JH; Hamblin AE; Lyon SG; Howard M
    Invest Radiol; 1980; 15(6 Suppl):S2-5. PubMed ID: 7203924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complement system in patients with IgE related and non IgE related bronchial asthma].
    Obtułowicz K; Kapusta M; Antoszczyk G
    Przegl Lek; 2002; 59(6):430-2. PubMed ID: 12418280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentrations of C reactive protein, alpha1 antitrypsin, and complement (C3, C4, C1 esterase inhibitor) before and during the Vuelta a Espańa.
    Semple SJ; Smith LL; McKune AJ; Hoyos J; Mokgethwa B; San Juan AF; Lucia A; Wadee AA
    Br J Sports Med; 2006 Feb; 40(2):124-7. PubMed ID: 16431998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-ionic iodinated dimeric versus monomeric X-ray contrast media: effects on complement factors in vivo].
    Böhm I; Speck U; Schild H
    Rofo; 2006 Mar; 178(3):306-12. PubMed ID: 16508838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7.
    Lathem WW; Bergsbaken T; Welch RA
    J Exp Med; 2004 Apr; 199(8):1077-87. PubMed ID: 15096536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remissions induced in hereditary angioneurotic edema with an attenuated androgen (danazol): correlation between concentrations of C1-inhibitor and the forth and second components of complement.
    Pitts JS; Donaldson VH; Forristal J; Wyatt RJ
    J Lab Clin Med; 1978 Oct; 92(4):501-7. PubMed ID: 712189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Behavior of esterase inhibitor C1 in patients with urticaria due to aspirin hypersensitivity].
    Grzelewska-Rzymowska I; Szmidt M; Rozniecki J; Ruta U
    Pneumonol Alergol Pol; 1993; 61(7-8):352-6. PubMed ID: 8401339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1 esterase inhibitor deficiency in X-linked hypogammaglobulinaemia: an anomaly fostering anaphylactoid reactions following intramuscular gammaglobulin administration.
    Pollack S; Cunningham-Rundles C; Good RA; Day NK
    Postgrad Med J; 1986 Oct; 62(732):939-42. PubMed ID: 2430274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1 inactivator and C3b inactivator in peripheral lymph of normal men.
    Olszewski WL; Lukomska B; Engeset A
    Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):79-86. PubMed ID: 7149928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Angioedema due to acquired complement-C1-inhibitor deficiency in a female patient with non-Hodgkin lymphoma and autoimmune hemolytic anemia].
    Beretta KR; Späth PJ; Pedrazzini A; Martinelli G; Cavalli F
    Schweiz Med Wochenschr; 1991 Jun; 121(25):943-7. PubMed ID: 1862309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A simplified method for the assessment of C1 esterase inhibitor function].
    Deguchi M; Takemura S; Ueda M; Kasamatsu Y; Yanagida K; Fukuda W; Okamoto M; Onodera H; Sugino S; Kondo M
    Ryumachi; 1990 Jun; 30(3):166-71. PubMed ID: 2244251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of C1-esterase inhibitor during emergency coronary artery bypass surgery in acute ST-elevation myocardial infarction.
    Thielmann M; Marggraf G; Neuhäuser M; Forkel J; Herold U; Kamler M; Massoudy P; Jakob H
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):285-93. PubMed ID: 16829095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular interaction between synthetic spirobutenolides and C1 esterase normal inhibitor].
    Bador P; Ollier-Hartmann MP; Paris J; Hartmann L
    C R Acad Sci III; 1986; 303(3):55-8. PubMed ID: 3093005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Level of plasma prekallikrein and its inhibitors in reactors and nonreactors during intravenous enhancement with contrast media.
    Aronen HJ; Kivisaari L; Torstila I; Paavonen T; Meri S; Karonen SL; Standertskjöld-Nordenstam CG
    Acta Radiol; 1992 Jul; 33(4):374-8. PubMed ID: 1378750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.